Case Report
COVID-19 Induced Cardiomyopathy Successfully Treated with Tocilizumab
Table 1
Demonstrating all lab values during her Hospital course.
| | Reference range | Hospital day 1 | Hospital day 2 | Hospital day 3 | Hospital day 5 | Hospital day 7 | Hospital day 9 |
| | Troponin I (NG/ML) | 0.020-0.040 | 4.295 | 4.294 | 0.858 | | | | | Brain Natiuretic peptide (pg/ml) | <99 | | 2,291(H) | | | 209(H) | | | Lactate dehydrogenase (U/L) | 125-243 | | 229 | 294 (H) | 229 | 330 (H) | 208 | | C-reactive protein(mg/L) | <3.0 | | >200(H) | >200(H) | 71.3(H) | 37.7(H) | 23.2(H) | | D-dimer (MG/L) | <0.49 | | 1.80 (H) | 1.56(H) | 0.96(H) | 0.95(H) | 1.25(H) | | Ferritin (NG/ML) | 7.0-271.0 | | 408.6(H) | 588.9(H) | 304.8(H) | 255.4 | 223.1 | | Interleukin-6 (pg/ml) | 0.00-12.2 | | 46.5 (H) | | | | |
|
|
